Systematic Review: Cardiac Resynchronization in Patients with Symptomatic Heart Failure
![Figure 3. CHF = congestive heart failure; CONTAK-CD = Guidant CONTAK CD CRT-D System Trial; MIRACLE = Multicenter InSync Randomized Clinical Evaluation; MIRACLE-ICD = Multicenter InSync Randomized Clinical Evaluation ICD [implantable cardioverter-defibrillator]; MUSTIC- AF = Multisite Stimulation in Cardiomyopathies Atrial Fibrillation; MUSTIC-SR = Multisite Stimulation in Cardiomyopathies Sinus Rhythm; RR = relative risk.](F3.medium.gif)
Figure 3. CHF = congestive heart failure; CONTAK-CD = Guidant CONTAK CD CRT-D System Trial; MIRACLE = Multicenter InSync Randomized
Clinical Evaluation; MIRACLE-ICD = Multicenter InSync Randomized Clinical Evaluation ICD [implantable cardioverter-defibrillator];
MUSTIC- AF = Multisite Stimulation in Cardiomyopathies Atrial Fibrillation; MUSTIC-SR = Multisite Stimulation in Cardiomyopathies
Sinus Rhythm; RR = relative risk.
Heart failure hospitalizations with cardiac resynchronization therapy (CRT) versus controls.
-
Published Ahead of Print
July 12, 2004,
Ann Intern Med
September 7, 2004
vol. 141
no. 5
381-390